Air Force denies early retirement to transgender troops, forcing them to choose between a lump-sum payment or involuntary discharge without benefits.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.
Air Force denies early retirement to transgender troops, forcing them to choose between a lump-sum payment or involuntary discharge without benefits.
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees its stock surge to a 7-year high amid optimism about its strategy and pipeline momentum.